Arrowstreet Capital’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-9,304
| Closed | -$592K | – | 1728 |
|
2024
Q2 | $592K | Buy |
9,304
+906
| +11% | +$57.6K | ﹤0.01% | 1312 |
|
2024
Q1 | $581K | Buy |
+8,398
| New | +$581K | ﹤0.01% | 1428 |
|
2022
Q1 | – | Sell |
-8,538
| Closed | -$393K | – | 1178 |
|
2021
Q4 | $393K | Buy |
+8,538
| New | +$393K | ﹤0.01% | 1309 |
|
2020
Q3 | – | Sell |
-37,587
| Closed | -$1.22M | – | 2312 |
|
2020
Q2 | $1.22M | Sell |
37,587
-55,536
| -60% | -$1.8M | ﹤0.01% | 1689 |
|
2020
Q1 | $3.79M | Sell |
93,123
-35,282
| -27% | -$1.44M | 0.01% | 840 |
|
2019
Q4 | $7.92M | Buy |
128,405
+122,205
| +1,971% | +$7.54M | 0.02% | 686 |
|
2019
Q3 | $452K | Buy |
+6,200
| New | +$452K | ﹤0.01% | 1348 |
|